Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Director/PDMR Shareholding

April 19, 2021
RNS Number : 8100V Renalytix AI PLC 19 April 2021     Renalytix AI plc   Director/PDMR Shareholding   New York , 19 April 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence -enabled in vitro   diagnostics company, focused on optimizing

Exclusive option agreement

April 14, 2021
RNS Number : 3696V Renalytix AI PLC 14 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform   Agreement provides RenalytixAI with exclusive option to access

Clinical Utility Study

April 8, 2021
RNS Number : 7571U Renalytix AI PLC 08 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions   Value of KidneyIntelX Testing Demonstrated by Data from 401

Clinical findings published in Diabetologia

April 6, 2021
RNS Number : 4091U Renalytix AI PLC 06 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure  

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

April 5, 2021
Clinical findings published in the April issue of Diabetologia, the official journal of the European Association for the Study of Diabetes NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- RenalytixAI plc (LSE: RENX) (NASDAQ: RNLX), announced today that KidneyIntelX™  more accurately predicted

Update on Finalization of MCIT Rule

March 15, 2021
RNS Number : 1874S Renalytix AI PLC 15 March 2021   Renalytix AI plc (" RenalytixAI " or the " Company ")   Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics   NEW YORK , March 15, 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ:
Displaying 21 - 30 of 192